Universität zu Köln

Oberthuer, Andre (2013). Genomic markers for neuroblastoma risk estimation: superseding tumor stage, age and MYCN? Biomark. Med., 7 (6). S. 905 - 909. LONDON: FUTURE MEDICINE LTD. ISSN 1752-0371

Full text not available from this repository.

Abstract

There is significant experimental evidence demonstrating that [incorporating genomic classification models into clinical diagnostic use] will allow us to better risk-adapt therapies and ultimately to improve our patients' outcomes.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Oberthuer, Andre UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-471348
DOI:	10.2217/bmm.13.97
Journal or Publication Title:	Biomark. Med.
Volume:	7
Number:	6
Page Range:	S. 905 - 909
Date:	2013
Publisher:	FUTURE MEDICINE LTD
Place of Publication:	LONDON
ISSN:	1752-0371
Language:	English
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language EXPRESSION-BASED CLASSIFICATION; GENE; STRATIFICATION; CHILDREN; PROJECT; CANCER; ALK Multiple languages Medicine, Research & Experimental Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/47134